Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06353971
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-04-03
Brief Title:
A Dose Escalation Trial of Safety PharmacokineticPharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria CIndU Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Sponsor:
Jasper Therapeutics Inc
Organization:
Jasper Therapeutics Inc
Organization Data
Organization:
Jasper Therapeutics Inc
Class:
INDUSTRY
Study ID:
JSP-CP-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jasper Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None